HWM vs NBIX · P/E 58, rev $4.86B vs P/E 45, rev $1.77B
Howmet Aerospace Inc (HWM) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Howmet Aerospace Inc (HWM) is a aerospace & defense company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported HWM revenue for 2026-06-30 was $4.86B. Net income was $1.11B. HWM currently screens at market cap $100.79B and trailing P/E 58.4.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
HWM currently screens at market cap $100.79B and trailing P/E 58.4. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the HWM and NBIX stock pages for the full models.
Not investment advice.